Seeing Is Believing

Currently out of the existing stock ratings of Nigel Dally, 73 are a SELL (11.44%), 378 are a HOLD (59.25%), 187 are a BUY (29.31%).
Analyst Nigel Dally, currently employed at MORGAN STANLEY, carries an average stock price target met ratio of 78.02% that have a potential upside of 38.49% achieved within 332 days.
Nigel Dally’s has documented 1,205 price targets and ratings displayed on 24 stocks. The coverage is on Financial Services, Healthcare, Communication Services, Basic Materials sectors.
Most recent stock forecast was given on PRU, Prudential Financial at 19-Oct-2026.
Analyst best performing recommendations are on ARQT (ARCUTIS BIOTHERAPEUTICS).
The best stock recommendation documented was for ARQT (ARCUTIS BIOTHERAPEUTICS) at 11/13/2023. The price target of $10 was fulfilled within 106 days with a profit of $7.89 (373.93%) receiving and performance score of 35.28.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 21-Jul-2026
$119
$-4.89 (-3.95%)
$116
19 days ago
(15-Oct-2026)
3/3 (100%)
$0.95 (0.80%)
17
Hold Since 25-Feb-2026
$116
$-7.89 (-6.37%)
$122
22 days ago
(12-Oct-2026)
5/6 (83.33%)
$1.46 (1.27%)
53
Hold Since 27-Aug-2015
$120
$-3.89 (-3.14%)
$125
22 days ago
(12-Oct-2026)
13/15 (86.67%)
$5.46 (4.77%)
148
Sell Since 02-Dec-2021
$101
$-22.89 (-18.48%)
$99
27 days ago
(07-Oct-2026)
8/14 (57.14%)
$-11.74 (-10.41%)
137
Sell Since 04-Dec-2020
$107
$-16.89 (-13.63%)
$102
27 days ago
(07-Oct-2026)
4/7 (57.14%)
$-5.74 (-5.09%)
43
Which stock is Nigel Dally most bullish on?
Which stock is Nigel Dally most reserved on?
What Year was the first public recommendation made by Nigel Dally?